Linde BangladeshDHA:LINDEBD +0.66%75 EBITDA Margin % is 22.52% as of Mar. 2026, which is 22% below its 10-year median of 28.90. GuruFocus rates DHA:LINDEBD with a GF Score™ of 75/100 and a GF Value™ of BDT855.28 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 1,585 Chemicals companies, Linde Bangladesh ranks better than 84.54% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Linde Bangladesh's EBITDA for the
three
months ended in Mar. 2026 was BDT133 Mil. Linde Bangladesh's Revenue for the
three
months ended in Mar. 2026 was BDT592 Mil. Therefore, Linde Bangladesh's EBITDA margin for the quarter that ended in Mar. 2026 was 22.52%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Linde Bangladesh EBITDA Margin % Related Terms
Linde Bangladesh EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Linde Bangladesh's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHA:LINDEBD vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, Linde Bangladesh's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Linde Bangladesh EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Linde Bangladesh's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Linde Bangladesh's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Linde Bangladesh (DHA:LINDEBD) has a EBITDA Margin % of 22.52% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Linde Bangladesh and its competitors. This is 22% below median its historical median of 28.90. Over the past decade, Linde Bangladesh's EBITDA Margin % has ranged from 20.18 to 348.14. According to the industry distribution chart, Linde Bangladesh ranks #245 out of 1585 companies in the Chemicals industry, placing it in the top 15.5%.
Is Linde Bangladesh's EBITDA Margin % too high?
Linde Bangladesh's current EBITDA Margin % of 22.52% is 22% below median its 10-year median of 28.90. Over the past 10 years, this metric has ranged from a low of 20.18 to a high of 348.14. The Chemicals industry median EBITDA Margin % is 9.63. Linde Bangladesh's value of 22.52% is 133.9% above this industry median. Based on the distribution chart, Linde Bangladesh ranks #245 out of 1585 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Linde Bangladesh has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Linde Bangladesh's EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Linde Bangladesh ranks #245 out of 1585 companies for EBITDA Margin %. This places Linde Bangladesh in the top 16% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.63. Linde Bangladesh's value of 22.52% is 133.9% above this benchmark. Historically, Linde Bangladesh's own EBITDA Margin % has ranged from 20.18 to 348.14 over the past decade. While the company's 10-year median is 28.90 vs. the industry median of 9.63, Linde Bangladesh has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.63, based on 1,585 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Linde Bangladesh's current EBITDA Margin % of 22.52% is 133.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Linde Bangladesh and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Linde Bangladesh's current EBITDA Margin % is 22.52%, which is 22% below median its own 10-year median of 28.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Linde Bangladesh stock overvalued right now?
Based on GuruFocus' analysis, Linde Bangladesh (DHA:LINDEBD) is currently considered Modestly Undervalued. The stock's GF Value™ is BDT855.28, compared to a current price of BDT700.00 — trading 18.2% below its estimated fair value. The current EBITDA Margin % is 22.52%, which is 22% below median its 10-year median of 28.90 and 133.9% above the Chemicals industry median of 9.63. Linde Bangladesh's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Linde Bangladesh (DHA:LINDEBD), the current EBITDA Margin % is 22.52% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Linde Bangladesh (DHA:LINDEBD) Overvalued in 2026?
Based on GuruFocus' analysis, Linde Bangladesh stock appears to be undervalued.
The current stock price of BDT700.00 is trading 18.2% below its estimated GF Value™ of BDT855.28.
GuruFocus considers Linde Bangladesh to be Modestly Undervalued.
Key valuation signals for DHA:LINDEBD:
EBITDA Margin %: 22.52% (22% below median its 10-year median of 28.90)
GF Value™: BDT855.28 vs. price of BDT700.00 (18.2% below fair value)
Industry Position: 133.9% above the Chemicals median (#245 of 1585)
No single metric tells the full story. See the DHA:LINDEBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Linde Bangladesh Ltd is a multinational industrial and medical gases company. The company provides products and services within a specific economic environment and supplies customers across a wide spectrum of industries ranging from chemicals and petrochemicals to steel. It operates 2 Air Separation Units (ASUs), 2 carbon dioxide manufacturing plants, and a DA manufacturing plant in the country. It serves various end markets such as chemicals and energy, food, beverage, electronics, healthcare, manufacturing, metals, defense, infrastructure, aerospace, and institutions. Its segments include Bulk Gases; Packaged Gas and Products; and the Healthcare business, which generates maximum revenue and comprises various medical gases, medical equipment, and medical pipelines.
75GF Score
Get the complete analysis for DHA:LINDEBD
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:LINDEBD has been successfully added to your 
